BESSEMER GROUP INC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$18,00083
+1283.3%
0.00%
Q4 2020$0
-100.0%
60.0%0.00%
Q3 2020$1,0000.0%60.0%0.00%
Q2 2020$1,000
-66.7%
6
-60.0%
0.00%
Q3 2018$3,000
+50.0%
150.0%0.00%
Q2 2018$2,0000.0%150.0%0.00%
Q1 2018$2,0000.0%150.0%0.00%
Q4 2017$2,0000.0%150.0%0.00%
Q3 2017$2,0000.0%150.0%0.00%
Q2 2017$2,0000.0%150.0%0.00%
Q1 2017$2,0000.0%150.0%0.00%
Q4 2016$2,000
-81.8%
15
-90.9%
0.00%
Q4 2015$11,000
+22.2%
165
+65.0%
0.00%
Q3 2015$9,000
-25.0%
1000.0%0.00%
Q2 2015$12,000
+33.3%
1000.0%0.00%
Q1 2015$9,000
+28.6%
1000.0%0.00%
Q4 2014$7,000
-56.2%
100
-50.0%
0.00%
Q3 2014$16,000
+45.5%
200
+100.0%
0.00%
Q2 2014$11,0001000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2020
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders